Syndicated Report

InCrowd Novel Coronavirus (COVID-19) Patient Tracking Report—Wave 2

May 14, 2020

Wave 3 of this Tracking Report is now available here!

As the novel coronavirus (COVID-19) pandemic continues to develop in the US, InCrowd wanted to understand how experiences, perceptions, and predictions of patients who are immunocompromised or have chronic conditions have changed over the course of this crisis.

We’d like to thank our friends at Rare Patient Voice for their help in sourcing this important research.

Methodology:

  • Method: 10-minute MicroSurvey via InCrowd & Rare Patient Voice
  • Crowds: Patients with Mild to Severe Illnesses
  • Sample Size: n=159 Total Patients (Previous Wave: 152), 83 Mild to Moderate Patients (Previous Wave: 77), 76 Moderate to Severe Patients (Previous Wave: 75)
  • Fielding Period: May 7th – 8th, 2020 (Previous Wave: March 25th – 26th)

InCrowd’s other COVID-19 Tracking Reports:

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.